戻る Agenda
END-TO-END DIGITAL CONTENT AVAILABILITY
Learning Objective : Understand the new clinical R&D Paradigm of smaller virtual research organizations working in networks Understand how technology can be used to facilitate the collection and sharing of content across the network Understand the importance of regulatory and eTMF interchange standards as an enabler
Speaker(s)
Enabling the new drug development paradigm through collaboration and interchange
Paul Fenton, MBA
Montrium, Canada
CEO
How Readily Available is Your eTMF?
Dorte Frejwald Christiansen, MA
NNIT, Denmark
Principal Consultant
Digital Preservation for Pharma: Comprehensive standard or flexible?
Pauline Sinclair
Tessella Ltd, United Kingdom
Digital Archiving Consultant